Rebate Management
No middlemen = increased visibility.
The medical pharmacy world is run, for the most part, by The Big Three PBMs acting as middlemen who can inflate drug costs with little transparency. In 2023, prescription drug dispensing generated $621 billion across retail, mail, long-term care, and specialty services while rebates and other discounts saved more than $330 billion for name-brand medications1. To effectively manage your rebate program and to ensure that you see the full rebate savings, we cut out the middlemen to provide you with visibility.
Direct contracting emphasis.
Trebia Med contracts directly with pharmaceutical manufacturers to bring you the best strategic options for your membership population. Choose the direct contracting plan that works best for you:
Medical Therapeutic Category Modular Approach
- Mix and match level of control by therapeutic category depending on your plan's needs
- Allows for flexibility where you don't have to be a one size fits all
- Take advantage of our various contracting options to make a preferred drug list that works for you
Biosimilars-first strategy.
Biosimilars have the power to save billions. With all the high-priced drugs in the pipeline, promoting biosimilar use just makes sense to your bottom line.
Provider network strategy and engagement.
A healthy relationship with your provider network is critical to your success. We’ll keep your provider network informed about your preferred drug strategy and ensure that you always benefit from reimbursements.
We work to keep your net cost down, too, and any rebate or contract negotiation savings goes to you. We believe in transparency so there are no hidden fees. Ever.